8-Bromo-7-(but-2-yn-1-yl)-3-methy1-1-[(4-methylquinazolin-2-yl)methyl]-3,7-dihydro-1H-purine-2,6-dione

医药中间体 · — · —

医药中间体Confidentiality：公开

INN / Generic Name: 8-Bromo-7-(but-2-yn-1-yl)-3-methy1-1-[(4-methylquinazolin-2-yl)methyl]-3,7-dihydro-1H-purine-2,6-dione
CAS No.: 853029-57-9
Dosage Form: —
Strength: —
Therapy Area: Pharmaceutical Intermediates
Indication: API: Linagliptin
Current Status: 官方中间体目录（API: Linagliptin）
GMP Certification: —
CEP: No
DMF Type: —
Stability Data: —
BE Required: Not required / waivable
Registration Pathway: FSO 供货（非注册物质）
MOQ: 询价
Lead Time: 询价
Price Range: 询价

Registrable Markets

Global

Process / Sequence / Exact Price